@article{f34c89aea9554a98b20300f610384140,
title = "American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy",
keywords = "Antiviral Agents/therapeutic use, Biomarkers/blood, DNA, Viral/blood, Hepatitis B/diagnosis, Hepatitis B Antibodies/blood, Hepatitis B Surface Antigens/blood, Hepatitis B virus/drug effects, Humans, Immunosuppressive Agents/adverse effects, Recurrence, Treatment Outcome, Viral Load, Virus Activation/drug effects",
author = "{American Gastroenterological Association Institute Clinical Guidelines Committee} and Reddy, {K Rajender} and Beavers, {Kimberly L} and Hammond, {Sarah P} and Lim, {Joseph K} and Falck-Ytter, {Yngve T} and Weinberg, {David S.}",
year = "2015",
month = dec,
doi = "10.1053/j.gastro.2014.10.039",
language = "English",
volume = "148",
pages = "215--9; quiz e16--7",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "1",
}